In a manner significantly different from NSCLC, SCLC tumor cells did not express PSMA, and there was no detectable correlation between the percentage of SCLC patients with PSMA-positive tumor NECs and the clinical parameters investigated in this study. Here, FOLH1 is linked to neoplasm.